← Leaderboards
Lucia Sobrin
Massachusetts Eye And Ear Infirmary
$6,603,039
Attributed
$7,445,037
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2012–24$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,445,037 · 8
By mechanism
R01$5,570,402 · 3
R21$930,500 · 2
P30$909,065 · 2
R13$35,070 · 1
Top collaborators
- Sudha K Iyengar3 shared
- Paulo J. M. Bispo2 shared
Most similar at Massachusetts Eye And Ear Infirmary
Same institution · by research overlap
- Janey L Wiggs$38,975,148
- Ayellet Vered Segre$5,398,681
Others in their field
Top investigators on “Blindness”
- Randall J Bateman · Washington University$137,189,188
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$96,562,493
Research focus
BlindnessEye DiseasesRisk FactorsSamplingGeneticInsightParticipantGenetic VariantTranscriptome SequencingExome SequencingVariantVisionGenomePhenotypeGenomic DataGenesCohortCollaborationsOphthalmologyVision ResearchDiagnosisAffectMorbidity - Disease RatePathogenicity
Grant awards (21)
Elucidating novel mechanisms for glucocorticoid-induced ocular hypertension$347,927
R01 · FY2024 · EY · contact PI
Advancing Eye Health through Data Science and Artificial Intelligence$35,070
R13 · FY2024 · EY · contact PI
Elucidating novel mechanisms for glucocorticoid-induced ocular hypertension$766,411
R01 · FY2023 · EY · contact PI
P30 Core Grant for Vision Research$181,813
P30 · FY2023 · EY · contact PI
Elucidating novel mechanisms for glucocorticoid-induced ocular hypertension$781,864
R01 · FY2022 · EY · contact PI
Advancing Diagnostics of Infectious Uveitis with MetagenomicAnalysis$206,125
R21 · FY2022 · EY
P30 Core Grant for Vision Research$181,813
P30 · FY2022 · EY · contact PI
Elucidating novel mechanisms for glucocorticoid-induced ocular hypertension$759,511
R01 · FY2021 · EY · contact PI
Advancing Diagnostics of Infectious Uveitis with MetagenomicAnalysis$255,000
R21 · FY2021 · EY
P30 Core Grant for Vision Research$181,813
P30 · FY2021 · EY · contact PI
Elucidating novel mechanisms for glucocorticoid-induced ocular hypertension$773,374
R01 · FY2020 · EY · contact PI
Identifying Protective and Risk Factors for Non-infectious Uveitis$205,802
R21 · FY2020 · EY · contact PI
P30 Core Grant for Vision Research$181,813
P30 · FY2020 · EY · contact PI
Unraveling the genetic architecture of diabetic retinopathy in South India$402,873
R01 · FY2019 · EY
Identifying Protective and Risk Factors for Non-infectious Uveitis$263,573
R21 · FY2019 · EY · contact PI
P30 Core Grant for Vision Research$181,813
P30 · FY2019 · EY · contact PI
Unraveling the genetic architecture of diabetic retinopathy in South India$402,499
R01 · FY2018 · EY
Unraveling the genetic architecture of diabetic retinopathy in South India$417,499
R01 · FY2017 · EY
Multi-ethnic GWAS of diabetic retinopathy: enhanced power using new methods$277,830
R01 · FY2014 · EY · contact PI
Multi-ethnic GWAS of diabetic retinopathy: enhanced power using new methods$269,325
R01 · FY2013 · EY · contact PI
Multi-ethnic GWAS of diabetic retinopathy: enhanced power using new methods$371,289
R01 · FY2012 · EY · contact PI